NovaBay Pharmaceuticals, Inc. Common Stock (NBY)
Frequently Asked Questions About NovaBay Pharmaceuticals, Inc. Common Stock (NBY)
Has NovaBay Pharmaceuticals received any awards or recognitions?
Yes, NovaBay Pharmaceuticals has garnered various awards and recognitions for its innovative products and contributions to healthcare. These accolades reflect the company’s commitment to improving patient outcomes and addressing health challenges.
How can I invest in NovaBay Pharmaceuticals?
To invest in NovaBay Pharmaceuticals, individuals can purchase shares through a broker or trading platform, as the company is publicly listed on the NYSE under the ticker symbol NBY. It's advisable to research the company’s performance and market trends before investing.
How does NovaBay address antibiotic resistance?
NovaBay Pharmaceuticals actively addresses antibiotic resistance by developing non-antibiotic treatments, such as its hypochlorous acid-based products, which can reduce the reliance on traditional antibiotics and provide effective patient care.
How does NovaBay ensure product safety and efficacy?
NovaBay Pharmaceuticals conducts rigorous clinical trials and follows stringent regulatory guidelines to ensure that all products are safe and effective for consumer use. Compliance with FDA regulations is a fundamental part of their development process.
How does NovaBay maintain customer support?
NovaBay Pharmaceuticals places a strong emphasis on customer support, providing healthcare professionals and patients with educational resources and responsive service to ensure they get the most benefit from their products.
How does NovaBay's technology work?
NovaBay's technology revolves around the use of hypochlorous acid, a naturally occurring substance that possesses antimicrobial properties. This technology allows for effective cleansing and management of bacterial presence without the use of traditional antibiotics.
Is NovaBay Pharmaceuticals publicly traded?
Yes, NovaBay Pharmaceuticals is publicly traded on the New York Stock Exchange under the ticker symbol NBY. This allows investors to buy shares and participate in the company's growth and potential profitability.
What are NovaBay's competitive advantages?
NovaBay's competitive advantages include its proprietary technology, a strong focus on unmet medical needs, and a clear strategy for marketing its products. The unique formulation of hypochlorous acid distinguishes it from competitors that rely on antibiotics.
What are the future prospects for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals has promising prospects for the future, particularly as interest in non-antibiotic treatments grows due to rising antibiotic resistance. The company continues to explore potential new products and indications to expand its market presence.
What are the key products of NovaBay Pharmaceuticals?
In addition to Avenova, NovaBay offers other products aimed at treating eye and skin conditions. Their product portfolio includes cleansers and treatments designed to promote optimal ocular health and skin hygiene.
What are the major markets for NovaBay's products?
NovaBay primarily operates in the eye care and dermatology markets. The company targets healthcare professionals and patients needing effective treatments for conditions like dry eye, eyelid hygiene, and skin infections.
What does NovaBay Pharmaceuticals, Inc. do?
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing innovative, non-antibiotic products for the eye care, dermatology, and other healthcare markets. The company's flagship product is Avenova, a solution used to cleanse and manage eyelid conditions associated with meibomian gland dysfunction.
What is Avenova?
Avenova is a prescription eye care product developed by NovaBay. It contains a proprietary formulation of pure hypochlorous acid, which is effective for cleaning and managing eyelid conditions, particularly those related to dry eye and blepharitis.
What is NovaBay's growth strategy?
NovaBay's growth strategy focuses on expanding its product offerings, enhancing brand awareness, and increasing market penetration in both the eye care and dermatology segments. The company aims to leverage its innovative technologies to address additional medical needs.
What is NovaBay's mission statement?
NovaBay Pharmaceuticals' mission is to enhance patient quality of life by providing innovative, safe, and effective therapeutic solutions for eye and skin conditions. Their aim is to meet unmet medical needs through scientific advancement.
What leadership does NovaBay have?
NovaBay Pharmaceuticals is led by a skilled team of executives with extensive experience in the pharmaceutical and biotech industries. This includes individuals with backgrounds in research, development, and commercial operations.
What role does research and development play in NovaBay's operations?
Research and development are central to NovaBay Pharmaceuticals' operations, enabling the company to innovate and create new products. They continuously invest in R&D to expand their portfolio and explore novel treatment options.
When was NovaBay Pharmaceuticals founded?
NovaBay Pharmaceuticals was founded in 2000, and since then, it has been committed to developing products that enhance patient care while addressing unmet medical needs.
Where is NovaBay Pharmaceuticals located?
The corporate headquarters of NovaBay Pharmaceuticals is located in Emeryville, California, which is part of the San Francisco Bay Area, a hub for biotechnology and pharmaceutical innovation.
What is the current price of NovaBay Pharmaceuticals, Inc. Common Stock?
The current price of NovaBay Pharmaceuticals, Inc. Common Stock is 0.8875
When was NovaBay Pharmaceuticals, Inc. Common Stock last traded?
The last trade of NovaBay Pharmaceuticals, Inc. Common Stock was at 12:30 pm EDT on August 21st, 2025
What is the market capitalization of NovaBay Pharmaceuticals, Inc. Common Stock?
The market capitalization of NovaBay Pharmaceuticals, Inc. Common Stock is 26.71M
How many shares of NovaBay Pharmaceuticals, Inc. Common Stock are outstanding?
NovaBay Pharmaceuticals, Inc. Common Stock has 30.10M shares outstanding.